Astrana HealthASTH +2.98%87 PS Ratio is 0.61 as of Jun. 26, 2026, which is 49% below its 10-year median of 1.19. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Astrana Health ranks better than 76.13% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Astrana Health's share price is $43.48.
Astrana Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $71.42. Hence, Astrana Health's PS Ratio for today is 0.61.
Warning Sign:
Astrana Health Inc stock PS Ratio (=0.61) is close to 1-year high of 0.64.
The historical rank and industry rank for Astrana Health's PS Ratio or its related term are showing as below:
ASTH'
s PS Ratio Range Over the Past 10 Years
Min: 0.29 Med: 1.19 Max: 12.56
Current: 0.61
During the past 13 years, Astrana Health's highest PS Ratio was 12.56. The lowest was 0.29. And the median was 1.19.
ASTH's PS Ratio is ranked better than 76.13% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs ASTH: 0.61
During the past 12 months, the average Revenue per Share Growth Rate of Astrana Health was 53.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 37.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 42.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 23.10% per year.
During the past 13 years, Astrana Health's highest 3-Year average Revenue per Share Growth Rate was 62.10% per year. The lowest was 1.30% per year. And the median was 34.90% per year.
Back to Basics: PS Ratio
Astrana Health (NAS:ASTH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Astrana Health PS Ratio Related Terms
Astrana Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Astrana Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Astrana Health's Share Price of today is $43.48. Astrana Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $71.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Astrana Health (ASTH) has a PS Ratio of 0.61 as of Jun. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Astrana Health and its competitors. This is 49% below median its historical median of 1.19. Over the past decade, Astrana Health's PS Ratio has ranged from 0.29 to 12.56. According to the industry distribution chart, Astrana Health ranks #158 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 23.9%.
Is Astrana Health's PS Ratio too high?
Astrana Health's current PS Ratio of 0.61 is 49% below median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 12.56. The Healthcare Providers & Services industry median PS Ratio is 1.47. Astrana Health's value of 0.61 is 58.5% below this industry median. Based on the distribution chart, Astrana Health ranks #158 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's PS Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #158 out of 662 companies for PS Ratio. This places Astrana Health in the top 24% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.47. Astrana Health's value of 0.61 is 58.5% below this benchmark. Historically, Astrana Health's own PS Ratio has ranged from 0.29 to 12.56 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 1.47, Astrana Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current PS Ratio of 0.61 is 58.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current PS Ratio is 0.61, which is 49% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current PS Ratio is 0.61, which is 49% below median its 10-year median of 1.19 and 58.5% below the Healthcare Providers & Services industry median of 1.47. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current PS Ratio is 0.61 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
PS Ratio: 0.61 (49% below median its 10-year median of 1.19)
GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
Industry Position: 58.5% below the Healthcare Providers & Services median (#158 of 662)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
